PHEOCHROMOCYTOMA/PARAGANGLIOMA
Clinical trials for PHEOCHROMOCYTOMA/PARAGANGLIOMA explained in plain language.
Never miss a new study
Get alerted when new PHEOCHROMOCYTOMA/PARAGANGLIOMA trials appear
Sign up with your email to follow new studies for PHEOCHROMOCYTOMA/PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare tumor disorder: belzutifan trial launches
Disease control Recruiting nowThis study looks at how well the drug belzutifan works for people with von Hippel-Lindau (VHL) syndrome, a genetic condition that causes tumors. About 100 participants will take belzutifan and be monitored for up to 2 years to see if their tumors shrink and how long the effects l…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Phase: PHASE2 • Sponsor: José Claudio Casali da Rocha • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
New drug shows promise for rare cancers in phase 2 trial
Disease control Recruiting nowThis study tests a drug called belzutifan in people with advanced cancers linked to a protein called HIF-2α, including rare tumors like pheochromocytoma/paraganglioma and VHL disease. The goal is to see if the drug can shrink tumors or stop them from growing. About 322 participan…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Hunt for hidden cancer genes: 1,500 families join landmark study
Knowledge-focused Recruiting nowThis research study aims to discover new genes that may cause cancer to run in families. Researchers will collect blood samples and health information from 1,500 people in families where multiple members have had childhood cancers. Participants will not receive direct treatment o…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 05:47 UTC